II
JAZZ icon

Inspire Investing’s Jazz Pharmaceuticals JAZZ Stock Holding History

Inspire Investing’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82M Buy
15,859
+10,361
+188% +$2.27M 0.16% 133
2026
Q1 		$1.04M Sell
5,498
-2,152
-28% -$376K 0.06% 325
2025
Q4 		$1.3M Buy
+7,650
New +$1.17M 0.12% 187
2025
Q2 		– Sell
-5,547
Closed -$689K – 847
2025
Q1 		$689K Buy
+5,547
New +$724K 0.08% 245
2024
Q4 		– Sell
-2,798
Closed -$312K – 839
2024
Q3 		$312K Buy
+2,798
New +$307K 0.03% 758

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Inspire Investing's JAZZ Position: Q2 2026 in Review

Inspire Investing increased its Jazz Pharmaceuticals (JAZZ) stake by 188% in Q2 2026, buying an estimated $2.27M and bringing the position to 15,859 shares worth $3.82M. The position accounts for 0.16% of the portfolio, ranked #133.

Inspire Investing first reported a position in JAZZ in Q3 2024 and has held it in 5 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Inspire Investing held 15,859 shares of Jazz Pharmaceuticals worth $3.82M as of Q2 2026.
  • Inspire Investing bought 10,361 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.27M.
  • Jazz Pharmaceuticals made up 0.16% of Inspire Investing's portfolio in Q2 2026, its #133 holding.
  • Inspire Investing first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.